170 related articles for article (PubMed ID: 22849758)
21. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone.
Mirkin S; Graham S; Revicki DA; Bender RH; Bernick B; Constantine GD
Menopause; 2019 Jan; 26(6):637-642. PubMed ID: 30601452
[TBL] [Abstract][Full Text] [Related]
22. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
Lin SQ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Zhou YZ; Wang ML; Zhu J; Chen SR; Su H; Yang CS; Wang SH; Zhang YZ; Dong XJ
Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973
[TBL] [Abstract][Full Text] [Related]
23. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
Zeleke BM; Bell RJ; Billah B; Davis SR
Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.
Constantine GD; Revicki DA; Kagan R; Simon JA; Graham S; Bernick B; Mirkin S
Menopause; 2019 May; 26(5):513-519. PubMed ID: 30516713
[TBL] [Abstract][Full Text] [Related]
26. Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms.
Gast GC; Pop VJ; Samsioe GN; Grobbee DE; Nilsson PM; Keyzer JJ; Wijnands-van Gent CJ; van der Schouw YT
Maturitas; 2011 Dec; 70(4):373-8. PubMed ID: 21978631
[TBL] [Abstract][Full Text] [Related]
27. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
[TBL] [Abstract][Full Text] [Related]
28. TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial.
Constantine GD; Simon JA; Kaunitz AM; Pickar JH; Revicki DA; Graham S; Bernick B; Mirkin S
Menopause; 2020 Nov; 27(11):1236-1241. PubMed ID: 33110039
[TBL] [Abstract][Full Text] [Related]
29. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
[TBL] [Abstract][Full Text] [Related]
30. The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women.
Andrikoula M; Baker D; Nesic J; Liao LM; Duka T; Prelevic GM
Climacteric; 2011 Oct; 14(5):544-50. PubMed ID: 21413865
[TBL] [Abstract][Full Text] [Related]
31. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.
Seritan AL; Iosif AM; Park JH; DeatherageHand D; Sweet RL; Gold EB
Menopause; 2010 Mar; 17(2):410-5. PubMed ID: 20216277
[TBL] [Abstract][Full Text] [Related]
32. Vasomotor menopausal symptoms are not associated with incidence of breast cancer in a population-based cohort of mid-aged women.
Johanneke van den Berg M; Mishra GD; van der Schouw YT; Herber-Gast GC
Eur J Cancer; 2014 Mar; 50(4):824-30. PubMed ID: 24361228
[TBL] [Abstract][Full Text] [Related]
33. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women.
Lipovac M; Chedraui P; Gruenhut C; Gocan A; Kurz C; Neuber B; Imhof M
Gynecol Endocrinol; 2012 Mar; 28(3):203-7. PubMed ID: 21870906
[TBL] [Abstract][Full Text] [Related]
34. Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study.
Gold EB; Flatt SW; Pierce JP; Bardwell WA; Hajek RA; Newman VA; Rock CL; Stefanick ML
Menopause; 2006; 13(3):423-33. PubMed ID: 16735939
[TBL] [Abstract][Full Text] [Related]
35. Is heart rate variability associated with frequency and intensity of vasomotor symptoms among healthy perimenopausal and postmenopausal women?
Jones SM; Guthrie KA; LaCroix AZ; Sternfeld B; Landis CA; Reed SD; Dunn A; Caan B; Cohen LS; Hunt J; Newton KM
Clin Auton Res; 2016 Feb; 26(1):7-13. PubMed ID: 26691637
[TBL] [Abstract][Full Text] [Related]
36. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
Stevens RE; Hanford K; Wason S; Cusack SL; Phelps KV
Int J Fertil Womens Med; 2000; 45(4):264-72. PubMed ID: 10997482
[TBL] [Abstract][Full Text] [Related]
37. Vasomotor Symptoms and Quality of Life Among Veteran and Non-Veteran Postmenopausal Women.
Katon JG; Gray KE; Gerber MR; Harrington LB; Woods NF; Weitlauf JC; Bean-Mayberry B; Goldstein KM; Hunt JR; Katon WJ; Haskell SG; McCutcheon SJ; Gass ML; Gibson CJ; Zephyrin LC
Gerontologist; 2016 Feb; 56 Suppl 1():S40-53. PubMed ID: 26220418
[TBL] [Abstract][Full Text] [Related]
38. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.
Archer DF; Seidman L; Constantine GD; Pickar JH; Olivier S
Am J Obstet Gynecol; 2009 Feb; 200(2):172.e1-10. PubMed ID: 19110224
[TBL] [Abstract][Full Text] [Related]
39. Vasomotor symptom characteristics: are they risk factors for incident diabetes?
Gray KE; Katon JG; LeBlanc ES; Woods NF; Bastian LA; Reiber GE; Weitlauf JC; Nelson KM; LaCroix AZ
Menopause; 2018 May; 25(5):520-530. PubMed ID: 29206771
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
Speroff L; Haney AF; Gilbert RD; Ellman H;
Menopause; 2006; 13(3):442-50. PubMed ID: 16735941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
